Galectin Therapeutics (GALT) Reports Q2 Loss of $0.21

Go back to Galectin Therapeutics (GALT) Reports Q2 Loss of $0.21
GALECTIN (NASDAQ: GALT) Delayed: 3.89 +0.18 (4.85%)
Previous Close $3.71    52 Week High $3.05 
Open $3.71    52 Week Low $0.49 
Day High $3.92    P/E N/A 
Day Low $3.68    EPS $-1.32 
Volume 1,065,897